期刊
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
卷 42, 期 6, 页码 609-613出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.injury.2011.03.029
关键词
Scaffold; Stem cells; BMPs; Osteoconduction; Osteoinduction; Bone regeneration; PRP; Bone defect
Over the last decades, the medical world has advanced dramatically in the understanding of fracture repair. The three components needed for fracture healing are osteoconduction, osteoinduction and osteogenesis. With newly designed scaffolds, ex vivo produced growth factors and isolated stem cells, most of the challenges of critical size bone defects have been resolved in vitro, and in some cases in animal models as well. However, there are still challenges needed to be overcome before these technologies can be fully converted from the bench to the bedside. These technological and biological advancements need to be converted to mass production of affordable products that can be used in every part of the world. Vascularity, full substation of scaffolds by native bone, and bio-safety are the three most critical steps to be challenged before reaching the clinical setting. (C) 2011 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据